Overview

Vitamin D Nasal Drops in Post COVID Parosmia

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:
0

Participant gender:
All

Summary

The current study will be a pilot study for a randomized controlled trial conducted on patients recruited from the outpatient clinic of the Otorhinolaryngology Department, Menoufia Faculty of Medicine To evaluate the effect of vitamin D nasal drops in the treatment of post COVID 19 parosmia

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Menoufia University

Treatments:

Budesonide
Cholecalciferol
Vitamin D

Criteria

nclusion Criteria:

- Patients should be more than 18 years old,

- Patients having a history of COVID 19 infection more than three months ago as
confirmed by PCR test,

- Patients having a post COVID parosmia,

- Patients having no history of systemic steroid administration over the last one month.

Exclusion Criteria:

- History of previous nasal surgery,

- Underlying systemic diseases (like diabetes mellitus, hypertension, or autoimmune
diseases),

- Hypersensitivity to vitamin D3.